| “Long‐term” survivors in doxorubicin‐treated patients with hepatocellular carcinoma DC Ihde, MJ Matthews, LB Seeff, PA Bunn, MH Cohen, JD Minna Proc Am Soc Clin Oncol 22, 457, 1981 | 3 | 1981 |
| [JDM], The University of Texas, Southwestern Medical Center at Dallas, Dallas, Texas 75390-8593; Department of Thoracic Medicine, The Prince Charles Hospital, Chermside … L Cancers¹, S Zöchbauer-Müller, KM Fong, AK Virmani, J Geradts, ... Cancer Research 61, 249-255, 2001 | | 2001 |
| 2 Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson B Dai, SY Yoo, G Bartholomeusz, RA Graham, M Majidi, S Yan, J Meng, ... | | |
| 227 NEOPLASMS OF THE LUNG JD MINNA Harrison's Principles of Internal Medicine 2, 1221, 1994 | | 1994 |
| 257 BRG1-Inactivating Mutations as Potential Predictive Markers for Aurora Kinase A-Targeted Therapy V Tagal, MG Roth, A Gazdar, JD Minna European Journal of Cancer, 79, 2012 | | 2012 |
| 362 Phenotypic plasticity in epithelial progenitors and mesenchymal carcinoma is regulated by Axl signaling A Engelsen, K Wnup-Lipinska, C Tiron, F Pelissier, T Jokela, G Haaland, ... European Journal of Cancer 50, 117, 2014 | | 2014 |
| 37 An epithelial to mesenchymal transition (EMT) gene expression signature identifies Axl as an EMT marker in non-small cell lung cancer (NSCLC) and head and neck cancer (HNC … L Byers, J Wang, L Diao, J Yordy, L Girard, M Story, K Coombes, ... Ejc Supplements 7 (8), 21, 2010 | 2 | 2010 |
| 388 An integrated molecular analysis of lung adenocarcinomas identifies potential therapeutic targets among TTF1-negative tumors RJ Cardnell, C Behrens, L Diao, Y Fan, X Tang, JD Minna, GB Mills, ... European Journal of Cancer, 124-125, 2014 | | 2014 |
| 3D spheroid/organoid models of lung cancer to study lung cancer pathogenesis and testing of new therapeutics B Gao, M Peyton, C Huang, H Park, L Girard, N Sorrelle, A Dayoub, ... Journal of Thoracic Oncology 12 (8), S1544, 2017 | 2 | 2017 |
| 3p21. 3 tumor suppressor cluster: prospects for translational applications L Ji, JD Minna, JA Roth Future oncology 1 (1), 79-92, 2005 | 114 | 2005 |
| 3PK, A NEW MAP KINASE ACTIVATED PROTEIN-KINASE, LOCATED IN THE SMALL-CELL LUNG-CANCER TUMOR-SUPPRESSOR GENE REGION R ALLIKMETS, F LATIF, R BERNAL, FM DUH, U SMOLA, ... AMERICAN JOURNAL OF HUMAN GENETICS 57 (4), 789-789, 1995 | | 1995 |
| 3pK, a new mitogen-activated protein kinase-activated protein kinase located in the small cell lung cancer tumor suppressor gene region G Sithanandam, F Latif, FM Duh, R Bernal, U Smola, H Li, I Kuzmin, ... Molecular and cellular biology, 1996 | 128 | 1996 |
| 3pK, a new mitogen-activated protein kinase-activated protein kinase located in the small cell lung cancer tumor suppressor gene region (vol 16, pg 868, 1996) G Sithanandam, F Latif, FM Duh, R Bernal, U Smola, H Li, I Kuzmin, ... MOLECULAR AND CELLULAR BIOLOGY 16 (4), 1880-1880, 1996 | | 1996 |
| 5-FLUOROURACIL (5-FU), METHYL CCNU (MECCNU), ADRIAMYCIN AND MITOMYCIN-C IN ADVANCED GASTRIC CANCER PA Bunn, J Nugent, DC Ihde, MH Cohen, BE Fossieck, JD MINNA PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH 19 (MAR), 358-358, 1978 | 2 | 1978 |
| 5-fluorouracil, methyl-CCNU, adriamycin, and mitomycin C in the treatment of advanced gastric cancer PA Bunn, JL Nugent, DC Ihde, MH Cohen, JL Eddy, JD Minna Cancer Treat Rep 62 (9), 1287-1293, 1978 | 26 | 1978 |
| 5′ CpG Island Methylation of the FHIT Gene Is Correlated with Loss of Gene Expression in Lung and Breast Cancer S Zochbauer-Muller, KM Fong, A Maitra, S Lam, J Geradts, R Ashfaq, ... Cancer research 61 (9), 3581-3585, 2001 | 437 | 2001 |
| 523 Small cell lung cancer molecular subtypes and vulnerability to immune checkpoint blockade B Nabet, H Hamidi, R Banchereau, S Morris, L Adler, M Srivastava, N Patil, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| 542 Abnormalities of FHIT and the FRA3B fragile site at 3p14. 2 in lung cancer and associated preneoplastic lesions KM Fong, EJ Biesterveld, A Virmani, II Wistuba, Y Sekido, SA Bader, ... Lung Cancer, 139, 1997 | | 1997 |
| 552 Comprehensive Genomic Profiling of Small Cell Lung Cancer Reveals SOX2 Amplification and MYCL1 Rearrangements CM Rudin, S Durinck, E Stawiski, JT Poirier, Z Modrusan, EA Bergbower, ... European Journal of Cancer, 170, 2012 | | 2012 |
| 602 AXL targeting with bemcentinb restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through innate immune cell mediated expansion of TCF1+ CD8 T cells H Li, Z Liu, L Liu, H Zhang, C Han, L Girard, H Park, A Zhang, C Dong, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | 2 | 2021 |
